Skip to search formSkip to main contentSkip to account menu

GK921

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus
Previously we have demonstrated transglutaminase 2 (TGase 2) inhibition abrogated renal cell carcinoma (RCC) using GK921 (3… 
2016
2016
Discovery of a novel target for renal cell carcinoma: transglutaminase 2
Instability of p53 in renal cell carcinoma (RCC) has not been previously associated with mutations, because 96% of clear-cell RCC… 
2013
2013
Abrogation of Renal Cell Carcinoma with Increase of P53 Level by Treatment of Transglutaminase 2 Inhibitor GK921
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)